A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial-Reference-Cited by-同舟云学术

A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial

Published:2024-06-28 Issue: Volume: Page:
ISSN:1618-7598
Container-title:The European Journal of Health Economics
language:en
Short-container-title:Eur J Health Econ

Author:

Minvielle Etienne,Leleu Henri^ORCID,Masseti Marc,Ferreira Arlindo,de Pouvourville Gérard,Palma Mario Di,Scotté Florian

Funder

Resilience, France

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10198-024-01702-1.pdf

Reference13 articles.

1. Agboola, S., Flanagan, C., Searl, M., Elfiky, A., Kvedar, J., Jethwani, K.: Improving outcomes in cancer patients on oral anti-cancer medications using a novel mobile phone-based intervention: Study design of a randomized controlled trial. JMIR Res. Protoc. Dec. 23(4), e79 (2014). https://doi.org/10.2196/resprot.4041

2. Basch, E., Deal, A.M., Dueck, A.C., et al.: Overall survival results of a trial assessing patient-reported outcomes for Symptom Monitoring during Routine Cancer Treatment. JAMA Jul. 11(2), 197–198 (2017). https://doi.org/10.1001/jama.2017.7156

3. Basch, E., Schrag, D., Henson, S., et al.: Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic Cancer: A Randomized Clinical Trial. JAMA Jun. 28(24), 2413–2422 (2022). https://doi.org/10.1001/jama.2022.9265

4. Doolin, J.W., Berry, J.L., Forbath, N.S., et al.: Implementing electronic patient-reported outcomes for patients with new oral chemotherapy prescriptions at an academic site and a community site. JCO Clin. Cancer Inf. Jun. 5, 631–640 (2021). https://doi.org/10.1200/CCI.20.00191

5. Mir, O., Ferrua, M., Fourcade, A., et al.: Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: The randomized phase 3 CAPRI trial. Nat. Med. Jun. 28(6), 1224–1231 (2022). https://doi.org/10.1038/s41591-022-01788-1

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program;The Oncologist;2024-09-14